BD Biosciences solutions for HIV provides absolute and percentage results of CD4 T lymphocytes to stage progression of HIV/AIDS, to guide treatment decisions for HIV-infected persons, and to evaluate the effectiveness of therapy.

Our commitment to help prevent, diagnose, and treat HIV/AIDS goes beyond the application of technology. We actively collaborate across public and private sectors to create effective and sustainable programs to build healthcare capacity.



BD collaborates across the private and public sectors to create effective and sustainable programs that help build healthcare capacity.

Product List

Product List

Instruments and reagents used to estimate CD4 lymphocyte counts and percentages.

* Does not constitute medical or legal advice, including with respect to regulatory practices or industry standards, specifically 21 CFR Part 58 Good Laboratory Practice for Nonclinical Laboratory Studies.